- Home
- SEZL vs HTFL Comparison
SEZL vs HTFL Comparison
Compare SEZL & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEZL
- HTFL
- Stock Information
- Founded
- SEZL 2016
- HTFL 2007
- Country
- SEZL United States
- HTFL United States
- Employees
- SEZL N/A
- HTFL N/A
- Industry
- SEZL Diversified Financial Services
- HTFL
- Sector
- SEZL Finance
- HTFL
- Exchange
- SEZL Nasdaq
- HTFL Nasdaq
- Market Cap
- SEZL 3.0B
- HTFL 2.8B
- IPO Year
- SEZL N/A
- HTFL 2025
- Fundamental
- Price
- SEZL $65.36
- HTFL $37.73
- Analyst Decision
- SEZL Buy
- HTFL Strong Buy
- Analyst Count
- SEZL 4
- HTFL 4
- Target Price
- SEZL $113.75
- HTFL $37.00
- AVG Volume (30 Days)
- SEZL 709.8K
- HTFL 319.9K
- Earning Date
- SEZL 11-05-2025
- HTFL 11-12-2025
- Dividend Yield
- SEZL N/A
- HTFL N/A
- EPS Growth
- SEZL 146.46
- HTFL N/A
- EPS
- SEZL 2.93
- HTFL N/A
- Revenue
- SEZL $371,794,890.00
- HTFL $148,540,000.00
- Revenue This Year
- SEZL $65.77
- HTFL $34.51
- Revenue Next Year
- SEZL $27.29
- HTFL $24.58
- P/E Ratio
- SEZL $23.97
- HTFL N/A
- Revenue Growth
- SEZL 92.95
- HTFL 44.32
- 52 Week Low
- SEZL $24.86
- HTFL $26.56
- 52 Week High
- SEZL $186.74
- HTFL $41.22
- Technical
- Relative Strength Index (RSI)
- SEZL 28.00
- HTFL N/A
- Support Level
- SEZL $70.63
- HTFL N/A
- Resistance Level
- SEZL $80.00
- HTFL N/A
- Average True Range (ATR)
- SEZL 4.46
- HTFL 0.00
- MACD
- SEZL -0.26
- HTFL 0.00
- Stochastic Oscillator
- SEZL 0.00
- HTFL 0.00
About SEZL Sezzle Inc.
Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.
About HTFL Heartflow Inc. Common Stock
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.